Table 1.
Baseline Pre-LTx Clinical Characteristics
| VARIABLE | PERCENTAGE |
|---|---|
| Sex | |
| Female | 50 |
| Age at Transplant (months) | |
| 0–3 | 4 |
| 3–6 | 17 |
| 6–9 | 42 |
| 9–12 | 37 |
| Race | |
| African American | 11 |
| Asian | 9 |
| Caucasian | 28 |
| Latino | 49 |
| Middle Eastern | 3 |
| Primary Diagnosis | |
| Autoimmune Liver Disease | 1 |
| Cholestatic Liver Disease | 60 |
| Cryptogenic Cirrhosis | 2 |
| Fulminant Hepatic Failure | 8 |
| Metabolic Liver Disease | 6 |
| Neonatal Hepatitis | 6 |
| Parenteral Nutrition Associated Liver Disease | 1 |
| Re-Transplantation | 14 |
| Tumor | 2 |
| VARIABLE | MEAN ± SD |
| Height (cm) | 64 ± 11 |
| Weight (kg) | 7.2 ± 3.2 |
| Body Mass Index (kg/m2) | 16.9 ± 3.9 |
| Albumin (g/dL) | 3.1 ± 0.7 |
| Bilirubin (mg/dL) | 16.7 ± 13.5 |
| Creatinine (mg/dL) | 0.5 ± 0.5 |
| INR (ratio) | 1.8 ± 1.0 |
| Calculated PELD Score | 20 ± 12 |
| Calculated Creatinine Clearance (ml/min/1.73 m2) | 89 ± 56 |
| Cold Ischemia Time (min) | 357 ± 194 |
| Warm Ischemia Time (min) | 56 ± 22 |
| Donor Body Mass Index (kg/m2) | 20 ± 5.1 |